NSD2 and cancer: Indeed, a genome-wide increase in H3K36me2 levels correlates with an increase in nucleosomal 5-methylcytosine levels; this, in turn, is correlated with an overexpression of the NSD2 (Nuclear Receptor Binding SET Domain Protein 2) cancer-driver and an upregulation in genes enriched in oncogenic pathways [24].